Cargando…

Differential sequential patterns supporting insulin therapy of new-onset type 1 diabetes

BACKGROUND: In spite of numerous research efforts on supporting the therapy of diabetes mellitus, the subject still involves challenges and creates active interest among researchers. In this paper, a decision support tool is presented for setting insulin therapy in new-onset type 1 diabetes. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Deja, Rafał, Froelich, Wojciech, Deja, GraŻyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349679/
https://www.ncbi.nlm.nih.gov/pubmed/25888901
http://dx.doi.org/10.1186/s12938-015-0004-x
Descripción
Sumario:BACKGROUND: In spite of numerous research efforts on supporting the therapy of diabetes mellitus, the subject still involves challenges and creates active interest among researchers. In this paper, a decision support tool is presented for setting insulin therapy in new-onset type 1 diabetes. METHODS: The concept of differential sequential patterns (DSPs) is introduced with the aim of representing deviations in the patient’s blood glucose level (BGL) and the amount of insulin injections administered. The decision support tool is created using data mining algorithms for discovering sequential patterns. RESULTS: By using the DSPs, it is possible to support the physician’s decisionmaking concerning changing the treatment (i.e., whether to increase or decrease the insulin dosage). The other contributions of the paper are an algorithm for generating DSPs and a new method for evaluating nocturnal glycaemia. The proposed qualitative evaluation of nocturnal glycaemia improves the generalization capabilities of the DSPs. CONCLUSIONS: The usefulness of the proposed approach was evident in the results of experiments in which juvenile diabetic patients actual data were used. It was confirmed that the proposed DSPs can be used to guide the therapy of numerous juvenile patients with type 1 diabetes.